SCR130 is a DNA non-homologous end joining (NHEJ) inhibitor based on SCR7; it specifically inhibits DNA end joining in a Ligase IV-dependent manner with minimal or no effect on Ligase III- or Ligase I-mediated ligation; it induces apoptosis and exhibits anticancer activity.